FDA inspection
AstraZeneca Dunkerque Production (AZDP): FDA inspection ending Feb 3, 2022
FDA inspection 1275115 · Voluntary Action Indicated (VAI) · Dordogne
Key facts
| Inspection ID | 1275115 |
|---|---|
| Firm | AstraZeneca Dunkerque Production (AZDP) |
| FEI number | 3003063819 |
| Address | Zone Entree Noord Gracht, 224 Avenue De La Dordogne |
| City | Dordogne |
| Country | France |
| Fiscal year | 2022 |
| Inspection end date | Feb 3, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data